Terms: = Head and neck cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Diagnosis
13 results:
1. Imaging of the Lymphatic Vessels for Surgical Planning: A Systematic Review.
van Heumen S; Riksen JJM; Bramer WM; van Soest G; Vasilic D
Ann Surg Oncol; 2023 Jan; 30(1):462-479. PubMed ID: 36171528
[TBL] [Abstract] [Full Text] [Related]
2. Combined Photothermotherapy and Chemotherapy of Oral Squamous Cell Carcinoma Guided by Multifunctional Nanomaterials Enhanced Photoacoustic Tomography.
Zeng S; Liu S; Lan Y; Qiu T; Zhou M; Gao W; Huang W; Ge L; Zhang J
Int J Nanomedicine; 2021; 16():7373-7390. PubMed ID: 34754191
[TBL] [Abstract] [Full Text] [Related]
3. Cortisol Deficiency in Lenvatinib Treatment of Thyroid cancer: An Underestimated Common Adverse Event.
Monti S; Presciuttini F; Deiana MG; Motta C; Mori F; Renzelli V; Stigliano A; Toscano V; Pugliese G; Poggi M
Thyroid; 2022 Jan; 32(1):46-53. PubMed ID: 34663079
[No Abstract] [Full Text] [Related]
4. Weighted Gene Co-Expression Network Analysis Identifies Hub Genes Associated with Occurrence and Prognosis of Oral Squamous Cell Carcinoma.
Ge Y; Li W; Ni Q; He Y; Chu J; Wei P
Med Sci Monit; 2019 Sep; 25():7272-7288. PubMed ID: 31562292
[TBL] [Abstract] [Full Text] [Related]
5. Identification of serpine1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.
Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T
Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621
[TBL] [Abstract] [Full Text] [Related]
6. Exosome-like Nanozyme Vesicles for H
Ding H; Cai Y; Gao L; Liang M; Miao B; Wu H; Liu Y; Xie N; Tang A; Fan K; Yan X; Nie G
Nano Lett; 2019 Jan; 19(1):203-209. PubMed ID: 30539641
[TBL] [Abstract] [Full Text] [Related]
7. Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy.
Colombo C; De Leo S; Di Stefano M; Vannucchi G; Persani L; Fugazzola L
J Clin Endocrinol Metab; 2019 Mar; 104(3):779-784. PubMed ID: 30383218
[TBL] [Abstract] [Full Text] [Related]
8. First evidence of treatment efficacy in metastatic carcinoma of the parotid gland with BRD4/NUT translocation.
Vulsteke C; Lurquin E; Debiec-Rychter M; Gheysens O; Nuyts S; Schoenaers J; Politis C; Mebis J; Hauben E; Clement PM
J Chemother; 2016 Jun; 28(3):242-6. PubMed ID: 26027633
[TBL] [Abstract] [Full Text] [Related]
9. serpine1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma.
Dhanda J; Triantafyllou A; Liloglou T; Kalirai H; Lloyd B; Hanlon R; Shaw RJ; Sibson DR; Risk JM
Br J Cancer; 2014 Nov; 111(11):2114-21. PubMed ID: 25268377
[TBL] [Abstract] [Full Text] [Related]
10. High expression of the urokinase plasminogen activator and its cognate receptor associates with advanced stages and reduced disease-free interval in papillary thyroid carcinoma.
Ulisse S; Baldini E; Sorrenti S; Barollo S; Gnessi L; Catania A; Pellizzo MR; Nardi F; Mian C; De Antoni E; D'Armiento M; Frati L
J Clin Endocrinol Metab; 2011 Feb; 96(2):504-8. PubMed ID: 21106716
[TBL] [Abstract] [Full Text] [Related]
11. cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model.
Wu CC; Chien KY; Tsang NM; Chang KP; Hao SP; Tsao CH; Chang YS; Yu JS
Proteomics; 2005 Aug; 5(12):3173-82. PubMed ID: 16035111
[TBL] [Abstract] [Full Text] [Related]
12. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.
Hasina R; Hulett K; Bicciato S; Di Bello C; Petruzzelli GJ; Lingen MW
Cancer Res; 2003 Feb; 63(3):555-9. PubMed ID: 12566295
[TBL] [Abstract] [Full Text] [Related]
13. Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (pai-1) in tissue and serum of head and neck squamous cell carcinoma patients.
Strojan P; Budihna M; Smid L; Vrhovec I; Skrk J
Eur J Cancer; 1998 Jul; 34(8):1193-7. PubMed ID: 9849478
[TBL] [Abstract] [Full Text] [Related]
